OGN vs STE · P/E 3.4, rev $6.40B vs P/E 25, rev $5.46B
Organon & Co (OGN) versus STERIS plc (STE) — a side-by-side from cached financials, not a winner call.
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
STERIS plc (STE) is a medical devices company listed on NYSE.
Latest reported OGN revenue for 2024-12-31 was $6.40B. Net income was $864.0M. Revenue was up 2.2% from 2023-12-31 to 2024-12-31. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
Latest reported STE revenue for 2025-03-31 was $5.46B. Net income was $616.1M. Revenue was up 284.6% from 2024-03-31 to 2025-03-31. STE currently screens at market cap $19.43B and trailing P/E 25.1.
OGN currently screens at market cap $2.52B and trailing P/E 3.4. STE currently screens at market cap $19.43B and trailing P/E 25.1.
Not investment advice. Open the OGN and STE stock pages for the full models.
Not investment advice.